FGFR alterations in pediatric cancers: Opportunity for targeted therapy

被引：0
|
作者：
LI, Ivan
Huo, Yuchen
Li, Gary
Zage, Peter
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2023年 / 22卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-23-A165
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A165
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Targeted Therapy for Pediatric Psoriasis
    Nogueira, Miguel
    Paller, Amy S.
    Torres, Tiago
    PEDIATRIC DRUGS, 2021, 23 (03) : 203 - 212
  • [32] Targeted Therapy for Pediatric Psoriasis
    Miguel Nogueira
    Amy S. Paller
    Tiago Torres
    Pediatric Drugs, 2021, 23 : 203 - 212
  • [33] FGFR3 alterations in bladder cancer: Sensitivity and resistance to targeted therapies
    Noeraparast, Maxim
    Krajina, Katarina
    Pichler, Renate
    Niedersuess-Beke, Dora
    Shariat, Shahrokh F.
    Gruenwald, Viktor
    Ahyai, Sascha
    Pichler, Martin
    CANCER COMMUNICATIONS, 2024, 44 (10) : 1189 - 1208
  • [34] TargetableBRAFandRAF1Alterations in Advanced Pediatric Cancers
    Rankin, Andrew
    Johnson, Adrienne
    Roos, Alison
    Kannan, Geoffrey
    Knipstein, Jeffrey
    Britt, Nicholas
    Rosenzweig, Mark
    Haberberger, James
    Pavlick, Dean
    Severson, Eric
    Vergilio, Jo-Anne
    Squillace, Rachel
    Erlich, Rachel
    Sathyan, Pratheesh
    Cramer, Stuart
    Kram, David
    Ross, Jeffrey
    Miller, Vince
    Reddy, Prasanth
    Alexander, Brian
    Ali, Siraj M.
    Ramkissoon, Shakti
    ONCOLOGIST, 2021, 26 (01): : E153 - E163
  • [35] New windows of surgical opportunity for gynecological cancers in the era of targeted therapies
    Peters, Inge
    Marchetti, Claudia
    Scambia, Giovanni
    Fagotti, Anna
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (03) : 352 - 362
  • [36] NOVEL FINDING IN PEDIATRIC LEIOMYOSARCOMA: EXPANDING SPECTRUM OF FGFR MUTATIONS IN CHILDHOOD CANCERS
    Persaud, Yogindra
    Gorsi, Hamza
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S144 - S145
  • [37] A novel finding in pediatric leiomyosarcoma: Expanding spectrum of FGFR rearrangements in childhood cancers
    Persaud, Yogindra
    Bagla, Shruti
    Shanti, Christina M.
    Shehata, Bahig M.
    Ravindranath, Yaddanapudi
    Gorsi, Hamza S.
    PEDIATRIC BLOOD & CANCER, 2021, 68 (04)
  • [38] Acquired FGF and FGFR alterations confer resistance to estrogen receptor (ER) targeted therapy in metastatic ER plus breast cancer
    Mao, Pingping
    Cohen, Ofir
    Kowalski, Kailey
    Kusiel, Justin
    Buendia, Jorge
    Exman, Pedro
    Wander, Seth A.
    Waks, Adrienne G.
    Winer, Eric P.
    Lin, Nancy U.
    Wagle, Nikhil
    CANCER RESEARCH, 2019, 79 (13)
  • [39] Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER+ Metastatic Breast Cancer
    Mao, Pingping
    Cohen, Ofir
    Kowalski, Kailey J.
    Kusiel, Justin G.
    Buendia-Buendia, Jorge E.
    Cuoco, Michael S.
    Exman, Pedro
    Wander, Seth A.
    Waks, Adrienne G.
    Nayar, Utthara
    Chung, Jon
    Freeman, Samuel
    Rozenblatt-Rosen, Orit
    Miller, Vincent A.
    Piccioni, Federica
    Root, David E.
    Regev, Aviv
    Winer, Eric P.
    Lin, Nancy U.
    Wagle, Nikhil
    CLINICAL CANCER RESEARCH, 2020, 26 (22) : 5974 - 5989
  • [40] Mechanisms of resistance to FGFR-targeted therapy in bladder cancer
    Pettitt, Geoffrey A.
    McPherson, Helen R.
    Hurst, Carolyn D.
    Burns, Julie E.
    Alder, Olivia A.
    Dunning, Matthew C.
    Knowles, Margaret A.
    CANCER RESEARCH, 2017, 77
12345